Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

被引:585
作者
Al-Ahmad, A
Rand, WM
Manjunath, G
Konstam, MA
Salem, DN
Levey, AS
Sarnak, MJ
机构
[1] Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Community Hlth, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Nephrol, Boston, MA 02111 USA
关键词
D O I
10.1016/S0735-1097(01)01470-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to evaluate the relationship between the level of kidney function, level of hematocrit and their interaction on all-cause mortality in patients with left ventricular (LV) dysfunction. BACKGROUND Anemia and reduced kidney function occur frequently in patients with heart failure. The level of hematocrit and its relationship with renal function have not been evaluated as risk factors for mortality in patients with LV dysfunction. METHODS We retrospectively examined the Studies Of LV Dysfunction (SOLVD) database. Glomerular filtration rate (GFR) was predicted using a recently validated formula. Kaplan-Meier survival analyses were used to compare survival times between groups stratified by level of kidney function (predicted GFR) and hematocrit. Cox proportional-hazards regression was used to explore the relationship of survival time to level of kidney function, hematocrit and their interaction. RESULTS Lower GFR and hematocrit were associated with a higher prevalence of traditional cardiovascular risk factors. In univariate analysis, reduced kidney function and lower hematocrit, in men and in women, were risk factors for all-cause mortality (p < 0.001 for both). After adjustment for other factors significant in univariate analysis, a 10 ml/min/1.73 m(2) lower GFR and a 1% lower hematocrit were associated with a 1.064 (95% CI: 1.033, 1.096) and 1.027 (95% CI: 1.015, 1.038) higher risk for mortality, respectively. At lower GFR and lower hematocrit, the risk was higher (p = 0.022 for the interaction) than that predicted by both factors independently. CONCLUSIONS Decreased kidney function and anemia are risk factors for all-cause mortality in patients with LV dysfunction, especially when both are present. These relationships need to be confirmed in additional studies. (C) 2001 by the American College of Cardiology.
引用
收藏
页码:955 / 962
页数:8
相关论文
共 31 条
  • [1] Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery
    Anderson, RJ
    O'Brien, M
    MaWhinney, S
    VillaNueva, CB
    Moritz, TE
    Sethi, GK
    Henderson, WG
    Hammermeister, KE
    Grover, FL
    Shroyer, AL
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1057 - 1062
  • [2] Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
    Bostom, AG
    Lathrop, L
    [J]. KIDNEY INTERNATIONAL, 1997, 52 (01) : 10 - 20
  • [3] CARSON JL, 1995, AM J SURG, V170, P32
  • [4] EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY
    COHN, JN
    ARCHIBALD, DG
    ZIESCHE, S
    FRANCIOSA, JA
    HARSTON, WE
    TRISTANI, FE
    DUNKMAN, WB
    JACOBS, W
    FRANCIS, GS
    FLOHR, KH
    GOLDMAN, S
    COBB, FR
    SHAH, PM
    SAUNDERS, R
    FLETCHER, RD
    LOEB, HS
    HUGHES, VC
    BAKER, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) : 1547 - 1552
  • [5] Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
    Culleton, BF
    Larson, MG
    Wilson, PWF
    Evans, JC
    Parfrey, PS
    Levy, D
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (06) : 2214 - 2219
  • [6] The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
    Dries, DL
    Exner, DV
    Domanski, MJ
    Greenberg, B
    Stevenson, LW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 681 - 689
  • [7] The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Murray, DC
    Barre, PE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) : 53 - 61
  • [8] EPIDEMIOLOGY OF HEART-FAILURE IN THE UNITED-STATES
    GILLUM, RF
    [J]. AMERICAN HEART JOURNAL, 1993, 126 (04) : 1042 - 1047
  • [9] THE ERYTHROCYTE SEDIMENTATION-RATE IN CONGESTIVE-HEART-FAILURE
    HABER, HL
    LEAVY, JA
    KESSLER, PD
    KUKIN, ML
    GOTTLIEB, SS
    PACKER, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) : 353 - 358
  • [10] Renal function, neurohormonal activation, and survival in patients with chronic heart failure
    Hillege, HL
    Girbes, ARJ
    de Kam, PJ
    Boomsma, F
    de Zeeuw, D
    Charlesworth, A
    Hampton, JR
    van Veldhuisen, DJ
    [J]. CIRCULATION, 2000, 102 (02) : 203 - +